ERIS Lifesciences Ltd
BSE:
NSE:ERIS
ERIS Share Price
BSE:
NSE:ERIS
Pharmaceuticals
Mid Cap
₹-
0 (0%)
Market Cap
₹17,403.45Cr
PE Ratio
49.94
ERIS Lifesciences Ltd Performance
▲
▲
▲
▲
ERIS Lifesciences Ltd Fundamentals
ERIS Lifesciences Ltd Delivery and Volume
About ERIS Lifesciences Ltd
Eris Lifesciences Limited was incorporated on January 25, 2007. Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007. Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on F
| Name | Designation |
|---|---|
| Amit Indubhushan Bakshi | Chairman & Managing Director |
| Kaushal Kamlesh Shah | Whole-time Director |
| Inderjeet Singh Negi | Whole-time Director |
| Krishnakumar Vaidyanathan | Whole Time Director & COO |
| Sujesh Vasudevan | Independent Non Exe. Director |
| Prashant Gupta | Independent Non Exe. Director |
| Rajeev Narotam Dalal | Independent Non Exe. Director |
| Kalpana Unadkat | Independent Non Exe. Director |
| Milind Talegaonkar | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
ERIS Lifesciences Ltd FAQs
How do I Buy ERIS Lifesciences Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase ERIS Lifesciences Ltd shares in BlinkX.
What is the Share Price of ERIS Lifesciences Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. ERIS Lifesciences Ltd's share price is ₹1274.2 as of 2025-01-15.
What is the PE ratio of ERIS Lifesciences Ltd?
ERIS Lifesciences Ltd's P/E ratio is 49.94 times as of 2025-01-15.
What is the PB ratio of ERIS Lifesciences Ltd?
ERIS Lifesciences Ltd's most recent financial reports indicate a price-to-book ratio of 6.28, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of ERIS Lifesciences Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. ERIS Lifesciences Ltd's market capitalization is ₹17403.45 Cr as on 2025-01-15.
What is the ROE of ERIS Lifesciences Ltd?
The current financial records of ERIS Lifesciences Ltd show a 12.63% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of ERIS Lifesciences Ltd?
According to ERIS Lifesciences Ltd's most recent financial filings, the company has a total asset value of ₹2361.63, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of ERIS Lifesciences Ltd?
The 52-week high/low price of a ERIS Lifesciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. ERIS Lifesciences Ltd's 52-week high and low as of 2025-01-15 are ₹1306 and ₹1266.5, respectively.
